Literature DB >> 33033004

Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase.

Izadora Fonseca Zaiden Soares1, Victoria Fernandez Comprido1, Bianca Raquel Ruoh Harn Scovoli Hsu1, Alzira Alves de Siqueira Carvalho2.   

Abstract

Subacute symmetrical proximal muscle weakness and persistent elevated creatine kinase levels are typical of immune-mediated necrotising myopathy (IMNM). These conditions are accompanied by copious myofibre necrosis, degeneration and regeneration with minimal to no inflammation on muscle biopsy. We report two cases (case 1 and case 2) of asymptomatic IMNM from different families with hyperCKaemia associated with positive anti-signal recognition particle (SRP) and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) antibodies, respectively, and we also reviewed the literature. There are only a few previous descriptions of patients with asymptomatic IMNM.The disease onset could be insidious and lead to delayed diagnosis and treatment. We recommend testing for the anti-HMGCR and anti-SRP antibodies in patients with idiopathic hyperCKaemia because they could show no symptoms of this disorder. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  muscle disease; neurology

Mesh:

Substances:

Year:  2020        PMID: 33033004      PMCID: PMC7545499          DOI: 10.1136/bcr-2020-235457

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.

Authors:  Ritu Valiyil; Livia Casciola-Rosen; Grace Hong; Andrew Mammen; Lisa Christopher-Stine
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

2.  Anti-SRP associated necrotizing autoimmune myopathy presenting with asymptomatically elevated creatine kinase.

Authors:  James D Triplett; Roger Pamphlett; Min-Xia Wang; Con Yiannikas
Journal:  Muscle Nerve       Date:  2019-01-09       Impact factor: 3.217

Review 3.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

Review 4.  Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Authors:  Lucile Musset; Yves Allenbach; Olivier Benveniste; Olivier Boyer; Xavier Bossuyt; Chelsea Bentow; Joe Phillips; Andrew Mammen; Philip Van Damme; René Westhovens; Anna Ghirardello; Andrea Doria; May Y Choi; Marvin J Fritzler; Heinrike Schmeling; Yoshinao Muro; Ignacio García-De La Torre; Miguel A Ortiz-Villalvazo; Nicola Bizzaro; Maria Infantino; Tiziana Imbastaro; Qinglin Peng; Guochun Wang; Jiří Vencovský; Martin Klein; Olga Krystufkova; Franco Franceschini; Micaela Fredi; Sophie Hue; Thibaut Belmondo; Katalin Danko; Michael Mahler
Journal:  Autoimmun Rev       Date:  2016-08-01       Impact factor: 9.754

5.  Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort.

Authors:  Sajini K Basnayake; Peter Blumbergs; Ju Ann Tan; Peter J Roberts-Thompson; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2014-02-05       Impact factor: 2.980

6.  In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.

Authors:  Laurent Drouot; Olivier Boyer; Cécile Bergua; Hélène Chiavelli; Yves Allenbach; Louiza Arouche-Delaperche; Christophe Arnoult; Gwladys Bourdenet; Laetitia Jean; Rachid Zoubairi; Nicolas Guerout; Michael Mahler; Olivier Benveniste
Journal:  Ann Rheum Dis       Date:  2018-10-11       Impact factor: 19.103

7.  Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.

Authors:  Yves Troyanov; Océane Landon-Cardinal; Marvin J Fritzler; José Ferreira; Ira N Targoff; Eric Rich; Michelle Goulet; Jean-Richard Goulet; Josiane Bourré-Tessier; Yves Robitaille; Julie Drouin; Alexandra Albert; Jean-Luc Senécal
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

8.  Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.

Authors:  Wen-Chen Liang; Akinori Uruha; Shigeaki Suzuki; Nobuyuki Murakami; Eri Takeshita; Wan-Zi Chen; Yuh-Jyh Jong; Yukari Endo; Hirofumi Komaki; Tatsuya Fujii; Yutaka Kawano; Madoka Mori-Yoshimura; Yasushi Oya; Jianying Xi; Wenhua Zhu; Chongbo Zhao; Yurika Watanabe; Keisuke Ikemoto; Atsuko Nishikawa; Kohei Hamanaka; Satomi Mitsuhashi; Norihiro Suzuki; Ichizo Nishino
Journal:  Rheumatology (Oxford)       Date:  2016-11-06       Impact factor: 7.580

9.  Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure - narrative review of the literature - case report.

Authors:  Alzira Alves de Siqueira Carvalho; Vinicius Gomes da Silva; Edmar Zanoteli; David Feder
Journal:  Ther Clin Risk Manag       Date:  2018-05-14       Impact factor: 2.423

10.  Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.

Authors:  Alzira Alves Siqueira Carvalho; Vinicius Gomes da Silva; Thaiane Fagundes Vieira; Pamela Oliveira Delgado; Roseli Corazini; David Feder; Fernando Luiz Affonso Fonseca
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more
  2 in total

1.  Refractory Statin-Induced Immune-Mediated Necrotizing Myositis: Challenges and Perils in Its Management.

Authors:  Chong Hsien Yeo; Aziman Yaakub; Margaret Choon Lee Wang; Sylvester Andrew Shim; Pui L Chong; Muhammad Abdul Mabood Khalil; Pemasiri U Telisinghe; Kian C Lim; Jackson Tan; Vui H Chong
Journal:  Cureus       Date:  2022-05-06

2.  Anti-HMGCR antibodies and asymptomatic hyperCKemia. A case report.

Authors:  Francesca Torri; Greta Ali; Lucia Chico; Gabriele Siciliano; Giulia Ricci
Journal:  Acta Myol       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.